Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06655870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 23, 2026 → Dec 16, 2026
Enrollment reduced 19% 52 → 42 participants
See other at-risk trials from Moderna

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reopened Show 5 more changesShow less
    • Primary and study completion pushed from Jun 23, 2026 to Dec 16, 2026
    • Enrollment reduced: 52 → 42 participants
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints revised (8)
    • Site details revised
  2. Primary and study completion dates: Dec 20, 2025 to Jun 23, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 29, 2024 to Oct 31, 2024
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Moderna
49 trials monitored
See 3 trials at risk
The purpose of this study is to test the safety of mRNA-0184 in healthy participants.
Trial Details
NCT Number NCT06655870
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 Healthy Participants
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov